Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Celli

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2015
(18)F-NaF PET/CT: EANM procedure guidelines for bone imagingM Beheshti, F M Mottaghy, F Paycha, et al.
Clinical and Experimental Medicine|November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomideI Rizzello, I Sacchetti, S Barbato, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2015
(18)F-NaF PET/CT: EANM procedure guidelines for bone imagingM Beheshti, F M Mottaghy, F Paycha, et al.
Clinical and Experimental Medicine|November 25, 2025
A multicenter observational retrospective study of second-line treatment with daratumumab-bortezomib-dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomideI Rizzello, I Sacchetti, S Barbato, et al.
Pageof 5